Case Study: Leading Pharmaceutical Company achieves 10-week global Phase III study setup and accelerated enrollment with Clario

Clario delivers study setup in 10 weeks for a global chronic weight management study

Leading Pharmaceutical Company ran a global Phase III chronic weight management study across 100+ sites and participants’ homes in North America, Europe and APAC and needed an accelerated setup to meet IRB/FPI timelines and capture ePRO and blood-glucose eDiary data. They engaged Clario to provide eCOA services, including remote and at-site data collection, device provisioning and assessment licensing.

Clario delivered provisioned on-site tablets and at-home handhelds, reused and re-engineered sponsor-specific documentation and pre-built, pre-validated assessments from its library, introduced a simplified 25-page Customer Charter and involved Solution Design and Programming teams early. As a result, Clario completed study setup in 10 weeks from kick-off, ensured devices arrived sooner so sites were ready faster, and accelerated participant enrollment while meeting the sponsor’s timelines.